In addition, in lung cancer cells, inhibition of either EZH2 or HIF-1α could enhance the other’s function [35], which suggests that the prognosis for tumors might be enhanced by simultaneously inhibiting EZH2 and HIF-1α. This evidence concerns the gene EZH2 and lung carcinoma.